EXPERIMENTAL STUDY OF OLIVOMYCIN, AN ANTITUMOUR ANTIBIOTIC.
D000818:Animals; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D002066:Busulfan; D002286:Carcinoma, Ehrlich Tumor; D007938:Leukemia; D007951:Leukemia, Myeloid; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin; D015122:Mercaptopurine; D051379:Mice; D009374:Neoplasms, Experimental; D009588:Nitrogen Mustard Compounds; D009848:Olivomycins; D010600:Pharmacology; D012106:Research; D012510:Sarcoma 180; D013852:Thiotepa; D014116:Toxicology
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D009848:Olivomycins; D013852:Thiotepa; D015122:Mercaptopurine; D002066:Busulfan
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BUSULFAN; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; LEUKEMIA, MYELOCYTIC; LYMPHOSARCOMA; MERCAPTOPURINE; MICE; NEOPLASMS, EXPERIMENTAL; NITROGEN MUSTARD COMPOUNDS; PHARMACOLOGY; SARCOMA 180, CROCKER; THIO-TEPA; TOXICOLOGIC REPORT